Business Wire

BLUETTI

12.3.2024 10:01:26 CET | Business Wire | Press release

Share
BLUETTI Launches New AC200L Portable Power Station in Europe on March 13

BLUETTI, the leading innovator in sustainable energy solutions, is thrilled to announce the upcoming launch of its latest product, the BLUETTI AC200L Portable Power Station, set to hit the European market on March 13. Designed to revolutionize portable power, the AC200L is a powerhouse of reliability, efficiency, and eco-friendliness.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240312603366/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

BLUETTI NEW COLLECTION AC200L (Photo: Business Wire)

Unrivaled Power and Durability

At the heart of the BLUETTI AC200L lies a robust 2,048Wh Lithium Iron Phosphate (LiFePO₄) battery, ensuring longevity and safety for over a decade with more than 3,000 life cycles. BLUETTI also backs it with an industry-leading 5-year warranty for added peace of mind. Equipped with a formidable 2,400W pure sine wave AC inverter(7,200W surge), extendable to 3,600W in Power Lifting mode, the AC200L is primed to handle high-demand appliances and sensitive electronics with ease.

Extendable Capacity and Fast Charging

The AC200L can independently power a 1,200W coffee maker, brewing about 31 cups of fresh coffee, and sustain a 150W fridge for over 12 hours. Additionally, it supports capacity expansion through extra batteries like the 2,048Wh B230 or two 3,072Wh B300 battery packs. This boosts its capacity to 4,096Wh or 8,192Wh, respectively, prolonging its runtime as required.

With 2,400W of fast charge capability, the AC200L can reach an 80% charge from the wall in as little as 45 minutes. In optimal weather conditions, it completes a 1,200W solar charge in approximately 2 hours, perfect for backup and on-the-go power needs.

Versatile Outlets and Intelligent Features

The AC200L boasts 10 outlets for diverse power needs, including a 48V DC port for RV life battery charging when paired with the optional BLUETTI D40 DC-DC charger, which can convert 12V power for most RV devices.

Moreover, users can adjust these settings and monitor/manage the battery via the BLUETTI app.

About BLUETTI

Committed to a sustainable future, BLUETTI has pioneered affordable green energy storage solutions for both indoor and outdoor use. Through initiatives like the LAAF (Lighting An African Family) program, BLUETTI will empower over 100,000 African families in rural areas, providing well-lit living spaces and equal learning opportunities. With an extensive and reliable product portfolio tailored for adventures, emergency backup power, and off-grid living, BLUETTI continues to make a tangible and positive impact on minimizing our carbon footprint worldwide. For more information on BLUETTI and its innovative products, visit BLUETTI's website.

Source: BLUETTI EU Marketing

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240312603366/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients27.4.2026 13:43:00 CEST | Press release

For Trade and Medical Media Only The study primary endpoint was met, showing non-inferiority vs. standard antimicrobial regimen in fungal-free survival at Day 90 Study showed favourable benefit for toxicity-related discontinuations and drug-drug interactions (DDIs) Rezafungin was well tolerated, with a safety profile comparable to standard antimicrobial regimens (SARs) Mundipharma today announced positive Phase III topline results from the global ReSPECT clinical trial evaluating REZZAYO® (rezafungin acetate) for prophylaxis of invasive fungal diseases (IFDs) in adult patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). The ReSPECT Phase III trial, one of the largest antifungal, multicentre, randomised, double-blind studies evaluated the efficacy and safety of once weekly rezafungin compared with a SAR for the prophylaxis of IFDs, including infections caused by Candida, Aspergillus, and Pneumocystis, in adults undergoing allogeneic HSCT. Patients undergoing a

vVARDIS Announces Investment from Apollo—Achieves Unicorn Status27.4.2026 13:00:00 CEST | Press release

Investment will support global commercial expansion of the Curodont™ technology platform, the first and only non-invasive peptide-containing formulations designed to treat tooth decay drill-free throughout the depth of the lesion vVARDIS Holding AG (“vVARDIS”), a high-growth dental medtech company pioneering non-invasive cavity treatment, today announced a strategic minority investment from Apollo-managed funds (“Apollo Funds”). The investment will support vVARDIS’ next phase of global growth and commercial expansion, including the continued rollout of its Curodont™ suite of products. The investment establishes vVARDIS as one of Europe’s few privately owned, billion-dollar-plus, healthcare companies. vVARDIS’ founders and co-CEOs, Drs. Haley and Goly Abivardi, will retain a substantial majority shareholding in the company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415938477/en/ Photo credit: Jos Schmid, Photographer

tesa Selects Kinaxis as the Digital Backbone for Global Integrated Business Planning Transformation27.4.2026 13:00:00 CEST | Press release

Kinaxis Maestro™ platform to serve as the foundation for a multi‑year transformation to resilient, globally orchestrated planning ecosystem Kinaxis® (TSX: KXS), a global leader in end‑to‑end supply chain orchestration, today announced that tesa SE, a global manufacturer of adhesive tapes and self-adhesive product solutions, has selected the Kinaxis Maestro™ platform as a core enabler of its global, multi‑year supply chain and integrated business planning (IBP) transformation. Following an extensive evaluation, tesa selected Kinaxis to support its evolution from regionally fragmented planning practices toward a centrally governed, globally orchestrated IBP operatingmodel. Kinaxis will support tesa in improving enterprise-wide transparency, strengthening resilience, and enabling faster, more informed decision making across an increasingly complex and volatile global supply chain network. With 130 years of innovation, tesa is one of the world’s leading manufacturers of adhesive tapes and

70% of Enterprise AI is Uncontrolled, Driving Hidden Risk, Cost and Slower ROI27.4.2026 10:00:00 CEST | Press release

Lenovo research highlights a growing AI execution gap as organizations struggle to control and operate AI across their environments AI is already being used across your organization, whether it has been formally approved or not. Employees are using AI with or without IT involvement, fueling the rise of ‘shadow AI’ across the enterprise, creating gaps in governance and control. This is no longer just an IT challenge. For Chief Information Security Officers, this shift is expanding the attack surface across devices, endpoints, and data flows, introducing unmanaged risk and increasing the likelihood of sensitive company data being exposed or accessed without proper controls. What this reveals is a growing AI execution gap: usage is accelerating, but control is not keeping pace. Based on a survey of 6,000 employees worldwide, Lenovo’s latest Work Reborn Report, Leading Your Workforce to Triumph with AI, finds that more than 70% of employees are using AI weekly, with up to one third operati

First Enterprise Quantum Computer Purchase in Japan: IQM to Deploy System to TOYO Corporation27.4.2026 08:00:00 CEST | Press release

First enterprise quantum computer purchase in Japan cements IQM's position as the global leader in deployed quantum computers The Radiance 20-qubit system will enable TOYO to explore various industry use cases, while advancing a hybrid quantum-HPC infrastructure. This will be the third quantum computer to be deployed by IQM in the Asia-Pacific region. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the purchase of its full-stack 20-qubit quantum computer by TOYO Corporation, marking the first enterprise quantum system deployment in Japan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426053944/en/ (From Left): Toshiya Kohno, Representative Director, President and CEO of TOYO Corporation, and Jan Goetz, CEO & Co-founder of IQM Quantum Computers. The Radiance 20-qubit system will be made available in both on-premises and cloud environments and will be delivered by the end of 2

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye